Randomized Trialhigh evidence
NF-kappa B Oligo DNA decoy provides 12 months of pain relief and disc height restoration for patients with chronic discogenic low back pain-a randomized clinical trial.
The spine journal : official journal of the North American Spine Society·November 1, 2025·PMID 40280496
Why it mattersAMG0103 represents a novel, mechanism-based approach targeting NF-κB-mediated inflammation and catabolism in disc degeneration. If confirmed, a single injection providing durable pain relief and structural improvement could address a major unmet need in chronic discogenic pain.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled